Although the clinical utility of genetic screening remains limited, several polymorphisms—particularly on chromosome 4q25 near the PITX2 gene—have been associated with a higher likelihood of AF recurrence following successful DCCV [63,64]. Here, PITX2 is linked to atrial fibrillation.